“…Predictors of CAM in Western countries, however, include being female (Molassiotis et al, 2005;Risberg et al, 2003), younger (Burstein et al, 1999;Risberg et al, 2003), more highly educated (Kao and Devine, 2000;Lerner and Kennedy, 1992), employed (Verhoef et al, 2005), professional (Downer et al, 1994), and having a higher income (Kao and Devine, 2000;McEachrane-Gross et al, 2006), while other studies showed inconsistent associations (Navo et al, 2004) or none (Tasaki et al, 2002). Although several studies report no relationship between CAM use and conventional treatment (McEachrane-Gross et al, 2006), advanced stage (Tas et al, 2005), or disease site (Fernandez et al, 1998), patients with lymphoma or cancer of the brain or CNS tend to use CAMs.…”